文献速递皮肤肿瘤毛发、甲与色素性疾病

白癜风患者癌症风险大型队列研究:发病率未升高

Evaluating cancer risk in a large cohort of 25,008 patients with vitiligo: Insights from a comprehensive cohort population-based study.
PubMed 文献 · J Am Acad Dermatol · 2024-12-02

基于Clalit健康服务数据库2000-2023年的人群队列研究,纳入25,008例白癜风患者和245,550名匹配对照,采用多因素Cox回归计算调整风险比。结论认为白癜风患者癌症筛查应遵循一般人群标准指南。

要点

  • 白癜风患者总体癌症发病率与对照人群无差异(调整HR 1.00)。
  • 白癜风患者黑色素瘤、肺癌和膀胱癌风险显著降低。
  • 白癜风患者癌症筛查应遵循一般人群标准指南。

核心结论

  • 白癜风患者癌症发病率未升高,筛查应遵循一般人群标准指南。

研究设计与样本

  • 基于Clalit健康服务数据库(2000-2023)的人群队列研究,纳入25,008例白癜风患者和245,550名匹配对照,采用多因素Cox回归计算调整HR。

临床怎么用

  • 白癜风患者无需进行超出一般人群指南的额外癌症筛查。

局限性

  • 二次分析涉及多重比较,可能影响结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current research presents inconsistent results concerning the incidence of various malignancies among patients with vitiligo. OBJECTIVES: To evaluate the risk of cancer in patients with vitiligo. METHODS: A population-based study was conducted using Clalit Health Services database (2000-2023) using a cohort study design. Adjusted hazard ratios (HRs) were calculated using multivariate Cox regressions. RESULTS: The study included 25,008 patients with vitiligo and 245,550 matched controls. The mean (SD) age of patients with vitiligo was 35.96 (22.39) years; 12,679 (50.70%) patients were men. There were 499 (95% confidence interval [CI]: 468-532) and 487 (95% CI: 476-497) incident cancer cases per 100,000 person-years among patients with and without vitiligo, respectively (adjusted HR: 1.00; 95% CI: 0.93-1.07; P = .999). Patients with vitiligo had a reduced risk of melanoma (adjusted HR: 0.70; 95% CI: 0.50-0.99; P = .0337), lung cancer (adjusted HR: 0.73; 95% CI: 0.57-0.93; P = .007), and bladder cancer (adjusted HR: 0.70; 95% CI: 0.52-0.94; P = .0138). LIMITATIONS: The secondary analysis involved multiple comparisons, which could potentially influence the results. CONCLUSION: Our study found that cancer incidence rates in patients with vitiligo are not elevated. Consequently, cancer screening for these patients should follow the standard guidelines recommended for the general population.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Schonmann Y, Cohen NT, Czarnowicki T, et al. Evaluating cancer risk in a large cohort of 25,008 patients with vitiligo: Insights from a comprehensive cohort population-based study. J Am Acad Dermatol. 2024. PMID: 39631697. doi:10.1016/j.jaad.2024.11.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。